近期交易合作|赛诺菲收购Blueprint 布局罕见免疫疾病领域;礼来与Camurus 合作押注长效肠促胰岛素

药菓
09 Jun

2025近期合作 & 交易事件我们毕业啦不负青春01赛诺菲95亿美元收购Blueprint02 BMS就PD-L1/VEGF双抗与BNT达成合作03 翰森与再生元就GLP-1/GIP激动剂达成合作04 新景智源与百济神州签署授权协议05璞正医药PDE4 抑制剂授权Transpire Bio06 礼来和Camurus就长效肠促胰液素达成合作07 智翔金泰就BCMAxCD3双抗达成国际授权合作01...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10